SOAR Act of 2025

U.S. Congress · HR2902 · In Committee

What the bill says

HR2902 · U.S. Congress · In Committee

Introduced 2025-04-10. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

View on Congress.gov →

Summary (plain-language)

Supplemental Oxygen Access Reform Act of 2025 or the SOAR Act of 2025 This bill establishes certain requirements with respect to the payment and provision of supplemental oxygen and related services under Medicare. For example, the bill provides for separate payments, indexed to inflation, of oxygen and related equipment, supplies, and services under Medicare (rather than under the competitive acquisition program). It also specifically covers services that are provided by respiratory therapists under Medicare and provides for an additional payment adjustment for these services. Additionally, the bill (1) requires the Centers for Medicare & Medicaid Services to develop an electronic template for providers to use when prescribing oxygen and related equipment, supplies, and services; and (2) establishes certain rights for beneficiaries receiving these items and services, such as the right to choose their suppliers and to receive clear communications and be informed about the services provided.

Sponsors

Text versions

  • Introduced in House — 2025-04-10 — XML

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2025-04-10Introduced in House
2025-04-10Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Lobbying on this bill

Showing 25 of 33 bill mentions.

Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.

Registrant (lobbying firm)ClientPeriodReported quarterly amountExtraction
BROWN & FORTUNATO, P.C. AMERICAN ASSOCIATION FOR HOMECARE (AAHOMECARE) Q2 2026 $80,000 Explicit
ACCENDRA HEALTH INC. ACCENDRA HEALTH INC. Q2 2026 $250,000 Explicit
ACCENDRA HEALTH INC. ACCENDRA HEALTH INC. Q2 2026 $250,000 Explicit
AMERICAN ASSOCIATION FOR HOMECARE AMERICAN ASSOCIATION FOR HOMECARE Q2 2026 $360,000 Explicit
THE NICKLES GROUP, LLC AMERICAN ASSOCIATION FOR HOMECARE (AAHOMECARE) Q2 2026 $60,000 Explicit
AMERICAN LUNG ASSOCIATION AMERICAN LUNG ASSOCIATION Q2 2026 $120,000 Probable
AMERICAN LUNG ASSOCIATION AMERICAN LUNG ASSOCIATION Q2 2026 $120,000 Probable
AMERICAN LUNG ASSOCIATION AMERICAN LUNG ASSOCIATION Q2 2026 $120,000 Probable
AMERICAN MEDICAL ASSOCIATION AMERICAN MEDICAL ASSOCIATION Q2 2026 $513,000 Explicit
AMERICAN MEDICAL ASSOCIATION AMERICAN MEDICAL ASSOCIATION Q2 2026 $5,130,000 Explicit
SIRONA STRATEGIES LLC ALLIANCE FOR CONNECTED CARE Q2 2026 $200,000 Explicit
SIRONA STRATEGIES LLC ALLIANCE FOR CONNECTED CARE Q2 2026 $200,000 Explicit
WILLIAMS AND JENSEN, PLLC ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") Q2 2026 $80,000 Explicit
MEDLINE MEDLINE Q2 2026 $400,000 Explicit
VANDERBILT UNIVERSITY MEDICAL CENTER VANDERBILT UNIVERSITY MEDICAL CENTER Q2 2026 $60,000 Explicit
CYSTIC FIBROSIS FOUNDATION CYSTIC FIBROSIS FOUNDATION Q2 2026 $270,000 Explicit
CYSTIC FIBROSIS FOUNDATION CYSTIC FIBROSIS FOUNDATION Q2 2026 $270,000 Explicit
NVG, LLC ACCENDRA HEALTH INC. Q2 2026 $80,000 Explicit
WHITMER & WORRALL, LLC ROTECH HEALTHCARE INC. Q2 2026 $40,000 Explicit
BROWN & FORTUNATO, P.C. AMERICAN ASSOCIATION FOR HOMECARE (AAHOMECARE) Q1 2026 $80,000 Explicit
THE NICKLES GROUP, LLC AMERICAN ASSOCIATION FOR HOMECARE (AAHOMECARE) Q1 2026 $60,000 Explicit
ACCENDRA HEALTH INC. ACCENDRA HEALTH INC. Q1 2026 $280,000 Explicit
AMERICAN ASSOCIATION FOR HOMECARE AMERICAN ASSOCIATION FOR HOMECARE Q1 2026 $480,000 Explicit
AMERICAN LUNG ASSOCIATION AMERICAN LUNG ASSOCIATION Q1 2026 $160,000 Probable
AMERICAN LUNG ASSOCIATION AMERICAN LUNG ASSOCIATION Q1 2026 $160,000 Probable

Source: Senate LDA filings.